Be wary of a single number
A significant part of the sector sells a biological age score derived from epigenetic testing. It is an appealing product because it is simple and it photographs well. The reproducibility of these assays and their usefulness in guiding clinical decisions both remain contested in the literature. A clinic leading with a biological age figure while measuring neither body composition nor cardiorespiratory fitness is offering a headline rather than a clinical picture.
The useful question to put to any provider is what a given test will change about the plan. If the answer is nothing, the guest is paying for information rather than care.
What this means for inbound travel
South Africa’ s case as a medical wellness destination is genuinely strong. Clinical standards at the better facilities are internationally competitive, the physician-to-guest ratio is far more generous than in most European equivalents, and a comprehensive residential programme here typically costs a fraction of a comparable stay in Switzerland or the United States, where week-long programmes routinely run into the tens of thousands of euros before diagnostics are added. Add a Southern Hemisphere winter that reads as summer to the Northern European market, and the proposition largely makes itself.
The risk sits in the follow-up. A guest who returns to Zurich or Riyadh cannot easily come back for a consultation. Any programme sold into the inbound market should therefore include a structured remote review— repeat bloodwork taken locally, interpreted by the treating physician, and discussed in a scheduled consultation. Operators referring clients abroad should treat the absence of that component as disqualifying rather than as a minor omission.
Three further points are worth confirming in writing before a referral: that the facility is a registered medical practice and not a wellness business with clinical branding; that aregistered physician, not a health coach, interprets the results; and that there is a defined escalation pathway if a finding requires specialist referral or hospital care. Screening a guest and discovering something serious is not a failure of the programme.
Screening a guest and discovering something serious is not a failure of the programme. Having no plan for what happens next is.
On price
Comparing sticker prices across this market tells you very little, because the products are not comparable. A day assessment and a ten-night residential programme are different categories. The instructive comparison is what a fee actually contains: physician consultation time, the diagnostic suite itself, interpretation, a written protocol, and whether follow-up testing is included or invoiced separately afterwards. A lower headline figure that produces a report and no care pathway is the more expensive option in every sense that matters.
South Africa has the clinical talent, the infrastructure and the cost advantage to compete seriously in this category. What the market still lacks is disclosure— published outcomes, transparent governance, honest statements of what a programme does not do. The providers that close that gap first will define how the country is regarded internationally, long after the current enthusiasm for the word“ longevity” has settled.
Dr Anushka Reddy is registered with the HPCSA and certified as a longevity physician by the Geneva College of Longevity Science. She leads the clinical programme at Vivari Wellness | The Longevity Institute in Featherbrooke, Johannesburg. vivariwellness. co. za
Start with the consultation. Nothing is booked before it.
Telephone + 27 11 958 2261 | WhatsApp + 27 64 947 9633 info @ vivariwellness. co. za | vivariwellness. co. za